FY2026 EPS Forecast for SBC Medical Group Reduced by Analyst

Posted by Francis Steltz on Aug 21st, 2026

SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Free Report) – Equities researchers at Zacks Research dropped their FY2026 earnings estimates for shares of SBC Medical Group in a note issued to investors on Wednesday, August 19th. Zacks Research analyst M. Marin now anticipates that the company will post earnings per share of $0.42 for the year, down from their previous estimate of $0.49. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.48 per share.

Several other research firms also recently commented on SBC. Wall Street Zen raised SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 15th. Weiss Ratings reissued a “sell (d+)” rating on shares of SBC Medical Group in a report on Wednesday. Finally, BTIG Research restated a “buy” rating and set a $8.00 price target on shares of SBC Medical Group in a research note on Thursday, August 13th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $8.50.

Read Our Latest Research Report on SBC

SBC Medical Group Stock Performance

NASDAQ SBC opened at $3.68 on Friday. The firm has a market cap of $377.49 million, a P/E ratio of 7.83 and a beta of 0.59. SBC Medical Group has a 52-week low of $2.78 and a 52-week high of $5.07. The business’s 50-day moving average price is $3.14 and its 200 day moving average price is $3.54. The company has a quick ratio of 3.27, a current ratio of 3.31 and a debt-to-equity ratio of 0.09.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. The business had revenue of $49.19 million during the quarter, compared to analyst estimates of $45.37 million.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in SBC. BlackRock Inc. acquired a new stake in SBC Medical Group in the second quarter valued at about $2,846,000. Geode Capital Management LLC increased its position in SBC Medical Group by 37.6% during the 4th quarter. Geode Capital Management LLC now owns 262,043 shares of the company’s stock worth $1,129,000 after purchasing an additional 71,664 shares during the period. Segall Bryant & Hamill LLC acquired a new position in SBC Medical Group during the 1st quarter worth approximately $340,000. Millennium Management LLC purchased a new position in shares of SBC Medical Group during the 3rd quarter worth approximately $219,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of SBC Medical Group by 91.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,341 shares of the company’s stock worth $118,000 after buying an additional 13,074 shares in the last quarter. 60.82% of the stock is currently owned by institutional investors and hedge funds.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.